---
title: "下半年对冲策略：高盛详细说明了未来可能出现的棘手尾部风险"
type: "News"
locale: "zh-CN"
url: "https://longbridge.com/zh-CN/news/247869554.md"
description: "根据高盛的跨资产类别宏观对冲团队，目前市场正处于 “恰到好处” 的状态。进入下半年，较高的估值和混合的宏观数据指向短期内股票的负面不对称，而尾部风险的下降使得回调的潜在可能性高于反弹的可能性"
datetime: "2025-07-09T18:42:52.000Z"
locales:
  - [zh-CN](https://longbridge.com/zh-CN/news/247869554.md)
  - [en](https://longbridge.com/en/news/247869554.md)
  - [zh-HK](https://longbridge.com/zh-HK/news/247869554.md)
generator: "portal-rs"
---

# 下半年对冲策略：高盛详细说明了未来可能出现的棘手尾部风险

**The market is currently trading in a goldilocks regime**, according to Goldman's cross-asset class macro hedging team.

Moving into H2, elevated valuations & mixed macro data points to **negative asymmetry for Equities in the near team**, while the tail risk has declined the **potential for drawdowns is higher than the likelihood of a rally**.

### 相关股票

- [TAIL.US](https://longbridge.com/zh-CN/quote/TAIL.US.md)

## 相关资讯与研究

- [独家消息：白宫权衡如何利用《国防生产法》扩大美国石油炼油产能，消息人士称](https://longbridge.com/zh-CN/news/298755165.md)
- [美光台湾员工获得高达 68 个月的薪水：随着 HBM 供应成为关注点，罢工风险会有所缓解吗？](https://longbridge.com/zh-CN/news/298723975.md)
- [波音与工程师工会达成初步合同协议](https://longbridge.com/zh-CN/news/298778378.md)
- [市场焦点：Yarrow Bioscience因1.5亿美元增发股价下跌](https://longbridge.com/zh-CN/news/298721285.md)
- [摩根大通对 Hims & Hers 股票给予 “持有” 评级。其谨慎立场的原因是什么？](https://longbridge.com/zh-CN/news/298771060.md)

---
> **免责声明: 本文仅供参考，不构成任何投资建议。**